BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23816762)

  • 1. Identification of a candidate single-nucleotide polymorphism related to chemotherapeutic response through a combination of knowledge-based algorithm and hypothesis-free genomic data.
    Takahashi H; Kaniwa N; Saito Y; Sai K; Hamaguchi T; Shirao K; Shimada Y; Matsumura Y; Ohtsu A; Yoshino T; Takahashi A; Odaka Y; Okuyama M; Sawada J; Sakamoto H; Yoshida T
    J Biosci Bioeng; 2013 Dec; 116(6):768-73. PubMed ID: 23816762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method.
    Takahashi H; Kaniwa N; Saito Y; Sai K; Hamaguchi T; Shirao K; Shimada Y; Matsumura Y; Ohtsu A; Yoshino T; Doi T; Takahashi A; Odaka Y; Okuyama M; Sawada J; Sakamoto H; Yoshida T
    BMC Cancer; 2015 Oct; 15():718. PubMed ID: 26475168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a combination of a knowledge-based algorithm and 2-stage screening to hypothesis-free genomic data on irinotecan-treated patients for identification of a candidate single nucleotide polymorphism related to an adverse effect.
    Takahashi H; Sai K; Saito Y; Kaniwa N; Matsumura Y; Hamaguchi T; Shimada Y; Ohtsu A; Yoshino T; Doi T; Okuda H; Ichinohe R; Takahashi A; Doi A; Odaka Y; Okuyama M; Saijo N; Sawada J; Sakamoto H; Yoshida T
    PLoS One; 2014; 9(8):e105160. PubMed ID: 25127363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-SNP association test for complex diseases incorporating an optimal P-value threshold algorithm in nuclear families.
    Wang YT; Sung PY; Lin PL; Yu YW; Chung RH
    BMC Genomics; 2015 May; 16(1):381. PubMed ID: 25975968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
    Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Ann Surg Oncol; 2008 Aug; 15(8):2301-9. PubMed ID: 18506536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of fluoropyrimidine and cisplatin. A future application to gastric cancer treatment.
    Shimoyama S
    J Gastroenterol Hepatol; 2009 Jun; 24(6):970-81. PubMed ID: 19638079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.
    Geng R; Chen Z; Zhao X; Qiu L; Liu X; Liu R; Guo W; He G; Li J; Zhu X
    PLoS One; 2014; 9(12):e116027. PubMed ID: 25545243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and challenges in fluoropyrimidine pharmacogenomics and pharmacogenetics.
    Soong R; Diasio RB
    Pharmacogenomics; 2005 Dec; 6(8):835-47. PubMed ID: 16296946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pipeline design to identify key features and classify the chemotherapy response on lung cancer patients using large-scale genetic data.
    Valdés MG; Galván-Femenía I; Ripoll VR; Duran X; Yokota J; Gavaldà R; Rafael-Palou X; de Cid R
    BMC Syst Biol; 2018 Nov; 12(Suppl 5):97. PubMed ID: 30458782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib.
    Ma F; Sun T; Shi Y; Yu D; Tan W; Yang M; Wu C; Chu D; Sun Y; Xu B; Lin D
    Lung Cancer; 2009 Oct; 66(1):114-9. PubMed ID: 19201048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics and stomach cancer: an update.
    Toffoli G; Cecchin E
    Pharmacogenomics; 2007 May; 8(5):497-505. PubMed ID: 17465714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing an adjusted p-value threshold to control the family-wide type 1 error in genome wide association studies.
    Duggal P; Gillanders EM; Holmes TN; Bailey-Wilson JE
    BMC Genomics; 2008 Oct; 9():516. PubMed ID: 18976480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients.
    Marcuello E; Altés A; del Rio E; César A; Menoyo A; Baiget M
    Int J Cancer; 2004 Dec; 112(5):733-7. PubMed ID: 15386371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between insulin-like growth factor axis gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX.
    Oh SY; Shin A; Kim SG; Hwang JA; Hong SH; Lee YS; Kwon HC
    Oncotarget; 2016 May; 7(21):31204-14. PubMed ID: 27144430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.
    Won HH; Lee J; Park JO; Park YS; Lim HY; Kang WK; Kim JW; Lee SY; Park SH
    Cancer; 2012 Jun; 118(11):2828-36. PubMed ID: 22020760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A powerful method for combining P-values in genomic studies.
    Chen HS; Pfeiffer RM; Zhang S
    Genet Epidemiol; 2013 Dec; 37(8):814-9. PubMed ID: 23959976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenomics of the first-line treatment for gastric cancer: advances in the identification of genomic biomarkers for clinical response to chemotherapy].
    Castro-Rojas C; Ortiz-Lópezj R; Rojas-Martínez A
    Invest Clin; 2014 Jun; 55(2):185-202. PubMed ID: 24974634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cancer pharmacogenetics: progress or old tripe?
    Patel JN; Fuchs CS; Owzar K; Chen Z; McLeod HL
    Pharmacogenomics; 2013 Jul; 14(9):1053-64. PubMed ID: 23837480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of IGF2BP2, KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic gastric cancer treated with EOF regimen.
    Liu X; Chen Z; Zhao X; Huang M; Wang C; Peng W; Yin J; Li J; He G; Li X; Zhu X
    Pharmacogenomics; 2015; 16(9):959-70. PubMed ID: 26115082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics and stomach cancer.
    Toffoli G; Cecchin E
    Pharmacogenomics; 2004 Sep; 5(6):627-41. PubMed ID: 15335285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.